How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress
- PMID: 36830041
- PMCID: PMC9952211
- DOI: 10.3390/antiox12020483
How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress
Abstract
SARS-CoV-2 induces a broad range of clinical manifestations. Besides the main receptor, ACE2, other putative receptors and co-receptors have been described and could become genuinely relevant to explain the different tropism manifested by new variants. In this study, we propose a biochemical model envisaging the competition for cysteine as a key mechanism promoting the infection and the selection of host receptors. The SARS-CoV-2 infection produces ROS and triggers a massive biosynthesis of proteins rich in cysteine; if this amino acid becomes limiting, glutathione levels are depleted and cannot control oxidative stress. Hence, infection succeeds. A receptor should be recognized as a marker of suitable intracellular conditions, namely the full availability of amino acids except for low cysteine. First, we carried out a comparative investigation of SARS-CoV-2 proteins and human ACE2. Then, using hierarchical cluster protein analysis, we searched for similarities between all human proteins and spike produced by the latest variant, Omicron BA.1. We found 32 human proteins very close to spike in terms of amino acid content. Most of these potential SARS-CoV-2 receptors have less cysteine than spike. We suggest that these proteins could signal an intracellular shortage of cysteine, predicting a burst of oxidative stress when used as viral entry mediators.
Keywords: ACE2; ROS; SARS-CoV-2; SARS-CoV-2 receptor; amino acid availability; cysteine; glutathione; spike.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.mBio. 2022 Apr 26;13(2):e0009922. doi: 10.1128/mbio.00099-22. Epub 2022 Mar 10. mBio. 2022. PMID: 35266815 Free PMC article.
-
Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.J Virol. 2020 Sep 29;94(20):e00902-20. doi: 10.1128/JVI.00902-20. Print 2020 Sep 29. J Virol. 2020. PMID: 32699095 Free PMC article.
-
ACE2-Independent Alternative Receptors for SARS-CoV-2.Viruses. 2022 Nov 16;14(11):2535. doi: 10.3390/v14112535. Viruses. 2022. PMID: 36423144 Free PMC article. Review.
-
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.Proc Natl Acad Sci U S A. 2021 Mar 23;118(12):e2025373118. doi: 10.1073/pnas.2025373118. Proc Natl Acad Sci U S A. 2021. PMID: 33658332 Free PMC article.
-
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30. Phytomed Plus. 2023. PMID: 36597465 Free PMC article. Review.
Cited by
-
Effects of COVID-19 and medication used for treatment and symptom prevention on the antioxidant status.Pharmacol Rep. 2025 Apr;77(2):490-499. doi: 10.1007/s43440-025-00696-8. Epub 2025 Feb 3. Pharmacol Rep. 2025. PMID: 39899256
References
-
- Chiara M., D’Erchia A.M., Gissi C., Manzari C., Parisi A., Resta N., Zambelli F., Picardi E., Pavesi G., Horner D.S., et al. Next Generation Sequencing of SARS-CoV-2 Genomes: Challenges, Applications and Opportunities. Brief. Bioinform. 2021;22:616–630. doi: 10.1093/bib/bbaa297. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous